2026-02-17T06:36:49-06:00 2025-06-30 871353108 EISNER ADVISORY GROUP LLC 130 NORTH 18TH STREET SUITE 3000 PHILADELPHIA PA 191032757 990 2024-07-01 061671347 BARUCH S BLUMBERG INSTITUTE BARU 2154894900 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 LOUIS P KASSA III CEO 2154894900 2026-02-12 1 0 HELEN M MARTIN P01330899 2158818800 2024 2025-03-06 01:10:19Z LOUIS P KASSA III 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 14955466 0 X WWW.BLUMBERGINSTITUTE.ORG X 2002 PA THE MISSION OF THE BARUCH S. BLUMBERG INSTITUTE IS TO USE DISCOVERY SCIENCE TO FIND NEW THERAPIES FOR VIRAL HEPATITIS AND LIVER CANCER; TO ADVANCE ITS RESEARCH DISCOVERIES THROUGH TRADITIONAL SCHOLARSHIP AND EDUCATIONAL OPPORTUNITIES; TO NURTURE BIOTECHNOLOGY AND TO PROMOTE PUBLIC HEALTH OUTREACH PROGRAMS TO IMPROVE THE QUALITY OF LIFE FOR THOSE AFFECTED BY VIRAL HEPATITIS. 10 6 90 6 0 0 12784009 10565075 434123 379946 296827 534535 3028803 3060960 16543762 14540516 2768421 1705812 0 0 7316027 8208481 0 0 22880 6195833 5071611 16280281 14985904 263481 -445388 9632204 10531733 2668857 4320711 6963347 6211022 X THE MISSION OF THE BARUCH S. BLUMBERG INSTITUTE IS TO USE DISCOVERY SCIENCE TO FIND NEW THERAPIES FOR VIRAL HEPATITIS AND LIVER CANCER; TO ADVANCE ITS RESEARCH DISCOVERIES THROUGH TRADITIONAL SCHOLARSHIP AND EDUCATIONAL OPPORTUNITIES; TO NURTURE BIOTECHNOLOGY AND TO PROMOTE PUBLIC HEALTH OUTREACH PROGRAMS TO IMPROVE THE QUALITY OF LIFE FOR THOSE AFFECTED BY VIRAL HEPATITIS. 0 0 7572611 1005812 80000 RESEARCH - TO DISCOVER AND/OR ASSIST IN THE DISCOVERY OF THERAPEUTICS, DIAGNOSTICS, AND PATHOGENESIS OF MEDICALLY IMPORTANT DISEASES IN GENERAL AND VIRAL HEPATITIS AND RELATED DISEASES IN PARTICULAR. 1673670 1951637 B. LABS AT CIRA CENTER - BEGINNING IN JANUARY 2022, BSBI REPLICATED ITS SUCCESSFUL LIFE SCIENCES INCUBATOR MODEL BY PARTNERING WITH BRANDYWINE REALTY TRUST INCLUDING THE MANAGEMENT OF OPERATIONS, PROVIDING OF SERVICES TO AND RECRUITMENT OF COMPANIES FOR THE INCUBATOR. 812200 700000 1273265 PUBLIC HEALTH OUTREACH AND TRAINING - TO PROMOTE AWARENESS OF LIVER DISEASES AND CHRONIC DISEASES; TO PROMOTE EDUCATION AND TRAINING IN THE AREA OF LIVER DISEASE ALONG WITH DISCOVERY RESEARCH AND PUBLIC HEALTH. 184913 170083 ACADEMIC - THE BARUCH S. BLUMBERG INSTITUTE HAS PARTNERED WITH SCHOOLS AND HIGHER EDUCATION AND OTHER AGENCIES TO BRING ACADEMIC PROGRAMMING TO THE BIOTECHNOLOGY CENTER. 184913 170083 10243394 1 1 0 1 0 0 0 0 0 0 1 0 0 1 1 1 1 1 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 57 0 1 90 1 0 0 0 0 0 0 0 0 0 0 0 0 X 10 6 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 PA NJ NY CA X PATTI MCALOON VP OF FINANCE 2154894900 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 ELIZABETH SEEBER MBA CPA TREASURER 0.50 1.00 X X 0 0 0 LOUIS P KASSA MPA CEO/SECRETARY 15.00 25.00 X X 314899 0 40371 LOREN DANZIS ESQ DIRECTOR 0.50 0.50 X 0 0 0 JOEL ROSEN ESQ DIRECTOR 0.50 1.00 X 0 0 0 THOMAS SHENK PHD DIRECTOR 0.50 X 0 0 0 JU-TAO GUO PRESIDENT/SR VP FOR RESEARCH 40.00 X X 298718 0 37671 TIM BLOCK DIRECTOR 0.50 1.00 X 35898 0 1194 CHARI COHEN DIRECTOR (EFF 1/2025) 1.00 40.00 X 0 220197 42163 TONY FORD-HUTCHINSON DIRECTOR 0.50 X 0 0 0 NIK HEBLE ESQ DIRECTOR 0.50 X 0 0 0 RANDALL HYER MD PHD PRESIDENT (THRU 7/2024) 16.00 24.00 X 238261 0 31404 RICHARD PESTELL DISTINGUISHED PROFESSOR 40.00 X 272651 0 31853 JINHONG CHANG VICE PRESIDENT, DRUG DEVELOPMENT 40.00 X 277614 0 22491 MATTHEW BURKHARDT DIRECTOR OF B. LABS 40.00 X 182599 0 12909 YANMING DU PROFESSOR OF MEDICINAL CHEMISTRY 40.00 X 241967 0 30175 BOB CHRISTMAS CHIEF OPERATING OFFICER 40.00 X 236510 0 24923 2099117 220197 275154 21 0 1 0 METROPOLITAN FACILITY SERVICE GROUP LLC 780 FIFTH AVE KING OF PRUSSIA PA 19406 CLEANING SERVICE 186140 THE BELLES GROUP 1800 JFK BOULEVARD SUITE 1010 PHILADELPHIA PA 19103 LAWYER - PATENT WORK 133101 2 5750284 4814791 10565075 OTHER ACADEMIC 611600 170083 170083 OTHER PROGRAM SERVICE REVENUE 541900 129863 129863 RESEARCH CONTRACTS 541900 80000 80000 379946 83464 83464 5410 5410 826531 39490 414949 1 411582 39489 451071 39489 411582 MANAGEMENT FEES 541900 3038576 3038576 MISCELLANEOUS REVENUES 541900 16974 16974 3055550 14540516 3474985 0 500456 1705812 1705812 992271 458499 533772 5804727 3790237 2014490 115634 72780 42854 834769 521866 312903 461080 288250 172830 186150 186150 138638 138638 28140 28140 112200 112200 589671 448972 140699 1240520 384561 855959 157725 52466 104926 333 257858 257858 50541 50541 SUPPLIES 1173206 1156854 16352 MISCELLANEOUS 969215 652728 293940 22547 EQUIPMENT 167747 154161 13586 14985904 10243394 4719630 22880 1585292 3986092 474147 2747 1513797 1612802 359283 243267 3684531 2750781 862771 933750 1872158 1872032 284708 502691 2680048 1378352 9632204 10531733 1036698 635185 1499805 1632159 2185721 2668857 4320711 X 5815764 5017810 1147583 1193212 6963347 6211022 9632204 10531733 X -445388 -196935 -110002 X X 0 1 X 1 1 1 X 5902182 5880518 9115679 12784009 10565075 44247463 5902182 5880518 9115679 12784009 10565075 44247463 44247463 86430 74391 100789 105968 88874 456452 599722 1717588 2871517 3026476 3055550 11270853 55974768 2375770 0.79050 0.80920 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 0 0 1 112200 112200 0 PART II-B, LINE 1: THE ORGANIZATION CONTRACTS WITH FIRMS THAT PROVIDES GOVERNMENT RELATIONS SERVICES. THESE SERVICES INCLUDE MONITORING AND REPORTING TO THE ORGANIZATION OF LEGISLATIVE, REGULATORY AND ADMINISTRATIVE MATTERS AFFECTING HEPATITIS AND VIRUS RESEARCH. 3596104 2673660 922444 88427 77121 11306 933750 DUE FROM AFFILIATE 78085 OTHER ASSETS 25 SECURITY DEPOSIT 15847 DUE FROM AFFILIATE - RABBI TRUST 1284395 1378352 DEFERRED COMPENSATION 463256 DUE TO AFFILIATE 686754 DEFERRED REVENUE 1035711 2185721 X 14005981 0 14005981 534535 534535 14540516 14985904 0 14985904 0 14985904 PART X, LINE 2: THE INTERNAL REVENUE SERVICE HAS CLASSIFIED THE INSTITUTE AS EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. THE CONSOLIDATED ENTITIES, THE LLCS, ARE LIMITED LIABILITY COMPANIES WHICH ARE NOT SUBJECT TO INCOME TAXES. TOTAL FEDERAL AND STATE INCOME TAX EXPENSE FROM THE CONSOLIDATED ENTITY WAS $-0- FOR THE YEAR ENDED JUNE 30, 2025. U.S. GAAP REQUIRES MANAGEMENT TO EVALUATE TAX POSITIONS TAKEN AND RECOGNIZE A TAX LIABILITY, IF THE INSTITUTE HAS TAKEN AN UNCERTAIN TAX POSITION THAT MORE LIKELY THAN NOT WOULD NOT BE SUSTAINED UPON EXAMINATION BY A GOVERNMENT AUTHORITY. MANAGEMENT HAS ANALYZED THE TAX POSITIONS TAKEN BY THE INSTITUTE AND HAS CONCLUDED THAT AS OF JUNE 30, 2025, THERE ARE NO UNCERTAIN POSITIONS TAKEN OR EXPECTED TO BE TAKEN THAT WOULD REQUIRE RECOGNITION OF A LIABILITY OR DISCLOSURE IN THE CONSOLIDATED FINANCIAL STATEMENTS. THE INSTITUTE RECOGNIZES ACCRUED INTEREST AND PENALTIES ASSOCIATED WITH UNCERTAIN TAX POSITIONS, IF ANY. THERE WERE NO INCOME TAX RELATED INTEREST AND PENALTIES RECORDED FOR THE YEAR ENDED JUNE 30, 2025. PART XI, LINE 4B - OTHER ADJUSTMENTS: INTEREST INCOME 50,161. DIVIDEND INCOME 33,303. REALIZED GAINS 451,071. PART XII, LINE 4B - OTHER ADJUSTMENTS: LLC EXPENSES 1 HEPATITIS B FOUNDATION 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 232655669 501(C)(3) 700000 0 OPERATING SUPPORT UTAH STATE UNVIVERSITY 1415 OLD MAIN HILL LOGAN UT 84322 876000528 501(C)(3) 40494 0 RESEARCH GRANT JOHNS HOPKINS UNIVERSITY 12529 COLLECTIONS CENTER DRIVE CHICAGO IL 60693 520595110 501(C)(3) 204890 0 RESEARCH GRANT THOMAS JEFFERSON UNIVERSITY 833 CHESTNUT ST SUITE 900 PHILADELPHIA PA 19107 231352651 501(C)(3) 20234 0 RESEARCH GRANT GENELANCET BIOSCIENCES INC 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 843588486 89464 0 RESEARCH GRANT CURIA GLOBAL 29224 NETWORK PLACE CHICAGO IL 60673 141742717 65866 0 RESEARCH GRANT PHARMARON PO BOX 18326 PALATINE IL 60058 208419781 40551 0 RESEARCH GRANT BUCKS COUNTY BIOTECHNOLOGY CENTER INC 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 203672921 501(C)(3) 278038 0 RESEARCH GRANT CHARLES RIVER LABS 3121 US-209 STONE RIDGE NY 12484 760509980 263473 0 RESEARCH GRANT 5 4 PART I, LINE 2: THE ORGANIZATION MONITORS ON A MONTHLY BASIS THE USE OF GRANT FUNDS. EXPENSES ARE COMPARED TO BUDGETED CATEGORIES AND ALL SUPPORTING DOCUMENTATION IS AVAILABLE UPON REQUEST. X X X 0 0 0 0 0 0 0 0 0 LOUIS P KASSA MPA CEO/SECRETARY 314899 0 0 0 0 0 10478 0 29893 0 355270 0 0 0 JU-TAO GUO PRESIDENT/SR VP FOR RESEARCH 298718 0 0 0 0 0 7778 0 29893 0 336389 0 0 0 RICHARD PESTELL DISTINGUISHED PROFESSOR 266651 0 6000 0 0 0 8154 0 23699 0 304504 0 0 0 JINHONG CHANG VICE PRESIDENT, DRUG DEVELOPMENT 234614 0 43000 0 0 0 7142 0 15349 0 300105 0 0 0 YANMING DU PROFESSOR OF MEDICINAL CHEMISTRY 201467 0 40500 0 0 0 6210 0 23965 0 272142 0 0 0 RANDALL HYER MD PHD PRESIDENT (THRU 7/2024) 238261 0 0 0 0 0 7260 0 24144 0 269665 0 0 0 CHARI COHEN DIRECTOR (EFF 1/2025) 0 220197 0 0 0 0 0 5725 0 36438 0 262360 0 0 BOB CHRISTMAS CHIEF OPERATING OFFICER 222010 0 14500 0 0 0 7365 0 17558 0 261433 0 0 0 MATTHEW BURKHARDT DIRECTOR OF B. LABS 151299 0 31300 0 0 0 4612 0 8297 0 195508 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B THE 990 FORM IS REVIEWED BY THE FINANCE COMMITTEE AND THEN REPORTED ON TO THE INSTITUTE'S BOARD PRIOR TO BEING FILED. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION MONITORS THE CONFLICT OF INTEREST STATEMENT AND DISCLOSES ANY EXISTING OR POTENTIAL CONFLICT OF INTEREST. THE CONFLICT OF INTEREST STATEMENTS ARE REVIEWED ANNUALLY BY MANAGEMENT. APPLICABLE MEMBERS INCLUDE THE FOLLOWING: BOARD OF DIRECTORS; THE PRESIDENT, OFFICERS, AND THOSE INDIVIDUALS CLASSIFIED AS SENIOR MANAGEMENT STAFF; ALL MEMBERS OF THE BSBI COMMUNITY WHO ARE IN A POSITION TO INFLUENCE OR PLACE ORDERS WITH VENDORS, MANAGEMENT AND FACULTY; BY LEGAL CONTRACTUAL, BSBI POLICY OR OTHER REQUIREMENTS, WHO HAVE BEEN NOTIFIED BY THEIR IMMEDIATE SUPERVISOR THAT DISCLOSURE IS REQUIRED. FORM 990, PART VI, SECTION B, LINE 15 BENCHMARKING DATA FOR THE DELAWARE VALLEY REGION IS UTILIZED TO SET COMPENSATION FOR THE BARUCH S. BLUMBERG INSTITUTE'S SENIOR MANAGEMENT POSITIONS. ANNUAL REVIEWS ARE CONDUCTED TO EVALUATE OBJECTIVE PERFORMANCE CRITERIA (I.E. BOARD EVALUATES SENIOR MANAGEMENT). FORM 990, PART VI, SECTION C, LINE 19 THE FORM 990 IS AVAILABLE ON THE GUIDESTAR WEBSITE. NO OTHER INFORMATION IS PUBLICLY AVAILABLE. FORM 990, PART XI, LINE 9: LOSS ON REDUCTION OF OWNERSHIP IN OTHER INVESTMENTS -201,002. ALLOCATED LOSS IN OTHER INVESTMENTS -60,919. CHANGE IN DUE FROM AFFILIATE RELATED TO RABBI TRUST INCOME 151,919. FORM 990, PART XII, LINE 2C THE FINANCE COMMITTEE ASSUMES RESPONSIBILITY FOR OVERSIGHT OF THE AUDIT. NO CHANGES HAVE BEEN MADE TO THIS PROCESS FROM THE PRIOR YEAR. TRYPTABIO LLC 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 PA 0 0 BARUCH S BLUMBERG INSTITUTE HEPATITIS B FOUNDATION 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 232655669 OUTREACH AND EDUCATION PA 501(C)(3) 7 N/A 0 BUCKS COUNTY BIOTECHNOLOGY CENTER 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 203672921 RENTAL REAL ESTATE, FOSTERING RESEARCH AND EDUCATION PA 501(C)(3) 12, I HEPATITIS B FOUNDATION 0 HATCH BIOFUND MANAGEMENT LLC 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 MANAGEMENT OF HATCH BIOFUND GP PA BARUCH S BLUMBERG INSTITUTE RELATED 409365 63258 0 1 0.50000 0 1 0 1 0 0 0 0 0 0 1 1 0 0 1 0 1 0 0